Theator
PrivateLast Round
Series A
Extension
Jul 22, 2022
Total Funding Raised
$66.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Theator operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A Extension round in July 2022.
Theator is a healthcare technology company that provides an AI-powered surgical intelligence platform to analyze surgical video footage and generate actionable clinical insights.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Computer Vision, EHR & EMR, Quality Management
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theator Comparables
Compare Theator with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caresyntax | 84% | |
| Surgical Safety Technologies | 82% | |
| nSight Surgical | 81% |
For institutional investors. Book with your work email.
Theator Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 22, 2022 | ||||
| Series A | Feb 9, 2021 | ||||
| Seed | Apr 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Theator Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Seed, Series A Extension, Series A |
| StageOne Ventures | Series A Extension, Series A, Seed |
| Blumberg Capital | Series A Extension, Series A |
| Icon Ventures | Series A Extension, Series A |
| iAngels | Series A Extension, Series A, Seed |
| KdT Ventures | Series A, Seed |
| Insight Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 125% MoM, reaching 8.9K.
- Nov 8, 2025
Monthly visitors increased 35% MoM.
For institutional investors. Book with your work email.
Theator Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theator's valuation, stock price, and market status.
Is Theator a public or private company?
Theator is a private company.
What is the current stock price of Theator?
Theator is a private company, so its shares have no public market price. Caplight tracks Theator's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theator worth (valuation)?
Valuation information for Theator is not publicly available.
Can I buy Theator stock?
Theator shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theator's last funding round?
Theator's most recent funding round was Series A Extension on July 22, 2022.
Who are the main investors in Theator?
Key investors in Theator include StageOne Ventures, iAngels, KdT Ventures, Insight Partners.
Will Theator IPO soon?
No public IPO plans have been announced for Theator.
How can I track Theator secondary market activity?
Caplight tracks bids, offers, and trades in Theator's shares on secondary markets.